UNSPSC 51201653: COVID19 - Pfizer Biontech

The Pfizer-BioNTech COVID-19 vaccine is used to provide protection against COVID-19, caused by infection with the SARS-CoV-2 virus, by eliciting an immune response to the S antigen. The vaccine is used to reduce morbidity and mortality from COVID-19.

UNSPSC 51201653 COVID19 - Pfizer Biontech is a Commodity code that captures state and local procurement of COVID-19 vaccines and related immunization products. The code's nominal framing as Pfizer-BioNTech specific does not reflect the actual scope of recent state and local activity, which includes procurement of other vaccine types and manufacturers across public health jurisdictions. State and local health departments are the primary issuing bodies under this code, typically announcing sole source procurements or competitive solicitations for vaccine supply to support immunization programs and public health response initiatives.

The Mississippi State Department of Health posted a sole source procurement notice in July 2026 for Yellow Fever Vaccine from Sanofi Pasteur, Inc., with an objection deadline of August 3, 2026, illustrating the type of state health agency activity tagged to this code. The notice invites challenges to sole source designation through the Public Procurement Review Board process, a procedural pathway common in state vaccine acquisitions when departments assert single-source availability. Geographic activity in recent months centers on state health departments; the source shows no multi-state pattern or concentration by region. Quantity, contract term, and estimated value are not disclosed in posted notices, typical for vaccine procurements where supply agreements often remain under protective procurement closure or are negotiated confidentially between state health agencies and manufacturers.